HOME >> BIOLOGY >> NEWS
Novel, even unlikely drugs may curb childhood leukemia

Philadelphia, Pa.While survival rates for childhood leukemias have soared in the past 30 years, about a quarter of pediatric cases remain stubbornly resistant to treatment. As a new attack strategy, scientists are adapting recent discoveries about cell development to coax leukemia cells back to normal growth patterns or to reprogram them into committing suicide.

"Reaching the next level of leukemia treatment will require many new approaches that draw upon our expanding knowledge about how healthy cells differentiate during normal growth and development," said Beverly Lange, M.D., director of experimental therapeutics within the Division of Oncology at The Childrens Hospital of Philadelphia, who is an expert in these new attack strategies.

Unlike conventional cancer drugs, the newer drugs are based on detailed knowledge of cellular mechanisms that can be used to manipulate cancer cells in a way that is gentler to surrounding healthy cells.

Oncologists at Childrens Hospital are investigating a number of novel, even unlikely, drugs as highly specific, less toxic weapons against childhood leukemia. For example:
-- A form of vitamin A is being used to reprogram a cancer cell into becoming a harmless, normal white blood cell.
-- Borrowing from its use in traditional Chinese medicine, carefully controlled doses of arsenic can trigger cancer cells to commit suicide by mimicking the normal developmental process of "apoptosis," or programmed cell death.
-- A new type of leukemia drug, the bioengineered compound Glivec, can block the genetic signals that direct cancer cells to grow, while leaving normal cells largely unharmed.
-- The naturally occurring protein interleukin-2 may kick-start the bodys immune system to better fight leukemia.

Taming cancer cells

Some experimental new treatments rely on methods that neutralize or disrupt cancer cells rather than killing them outright in a frontal attack. "Most conventional ca
'"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
215-590-7332
Children's Hospital of Philadelphia
14-May-2001


Page: 1 2 3 4

Related biology news :

1. Goals unlikely to protect Gulf of Mexico shrimp industry
2. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
3. Sex selection for social reasons unlikely to skew gender balance in Germany and UK
4. An unlikely new weapon against a deadly bacteria in oysters: A virus
5. Suppressing entire immune system unlikely to be best way to treat autoimmune diseases, new findings show
6. Depressed heart attack survivors unlikely to change behavior
7. New model of staph drug resistance implicates unlikely protein
8. One in three physicians unlikely to get routine medical care
9. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
10. New and better drugs for tuberculosis goal of UH professor
11. New technique helps scientists reveal interactions between genes and drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... ... 17, 2018 , ... Maintenance of Certification (MOC) adds no ... of physicians surveyed by MDLinx, a medical news, information, and education website. The ... that many physicians are frustrated with the mandated MOC requirements that the medical ...
(Date:10/16/2018)... , ... October 16, 2018 ... ... provider of advanced software solutions for biopharmaceutical R&D, today announced Genedata Imagence®, ... high-content screening (HCS) images. The deep learning-based solution accelerates, by orders of ...
(Date:10/16/2018)... , ... October 16, 2018 , ... Our own cells ... discs in our spine. , So comments interventional spine and pain management specialist Jason ... enzymes and proteins, or stem cells harvested from a patient’s bone marrow are proving ...
Breaking Biology News(10 mins):
(Date:10/18/2018)... Calif. (PRWEB) , ... October 18, 2018 , ... ... CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received accreditation ... quality, operations, and patient safety. , Predicine received CAP accreditation for its Shanghai ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... and his associate, Dr. Michael Kang, are offering current and new patients the ... results thanks to the emerging, proven treatment technology known as Piezosurgery® . ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... Phytophthora spp. have been validated by USDA’s Animal and Plant Health Inspection Service ... use the assays with confidence and trust, knowing they will be able to ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... attended the first Congressional briefing on a revolutionary technology that effectively treats pain, ... founder of Infinity Healing, testified on how technology using photobiomodulation (PBM) has been ...
Breaking Biology Technology:
Cached News: